. In addition, we demonstrated that p53 protein of these is the product of the S. cerevisiae SIR2 gene, can bind to the NAD-dependent poly-ADP-ribose polywhich is involved in silencing HM loci that contain informerase. These observations led us to speculate that mation specifying yeast mating type, telomere position other NAD-dependent enzymes, notably Sir2 which was effects, and cell aging (Guarente, 1999) .
known to be involved in life span regulation in lower In yeast, SIR2 was thought to function as an NAD eukaryotes, might also be able to interact with p53. 
Results

plexes with p53 protein even without ectopic overexpression of these two proteins. To do this, we performed Physical Interaction of hSir2 with p53
immunoprecipitation of lysates of primary BJ human Our initial interest in Sir2 was motivated by its reported fibroblasts or MCF-7L human breast cancer cells with involvement in the DNA damage response and its ability our anti-hSir2 and p53 antibodies as described above to function as an NAD-dependent ADP ribosylase (Tanny (Figures 1C and 1D ). These observations indicated that et al., 1999); this latter trait allied it with other ADP ribosyhSir2 and p53 formed physical complexes with each lases that are activated in response to DNA damage. other in vivo under physiological conditions. However, However, soon after our work began, the function of no p53 or Sir2 proteins were detected when either a SIR2 as an NAD-dependent deacetylase was reported control antibody or IgG was used. As an additional con-(Imai et al., 2000; Smith et al., 2000). Independent of trol, lysates from Saos2 cells (lacking p53 expression) this, research of others had previously indicated that were subjected to immunoprecipitation in the same set the p53 protein is acetylated in response to DNA damage of experiments described above. Complexes between (Abraham et al., 2000; Sakaguchi et al., 1998). These hSir2 and p53 protein were not detectable in these exvarious findings reoriented our thinking to entertain the periments ( Figures 1C and 1D ). possibility that Sir2 acts as a deacetylase of p53, thereby
Comparison of the immunoprecipitable hSIR2 protein downmodulating its function. present in MCF-7L cells with the amount present in preIn order to study the possible functional interaction cipitates generated with anti-p53 antibody allowed us to between p53 and hSir2, we isolated and introduced a estimate that approximately 0.0005% of the total hSir2 full-length human hSIR2 SIRT1 cDNA clone (Experimental protein was present in physical complexes with p53 Procedures) into a pBabe-based retroviral expression ( Figure 1C ). Conversely, we estimated that in MCF-7L vector that also carries a puromycin resistance gene as cells, approximately 1% of the total p53 could be found a selectable marker. The resulting construct was termed in physical complexes with the hSIR2 protein ( Figure 1D ). pYESir. A retroviral construct bearing a derived, mutant allele of the hSIR2 SIRT1 gene and termed pYESirHY was Deacetylation of p53 by hSir2 In Vitro constructed and used in parallel. This mutant allele Since hSir2 could form physical complexes with p53, specifies an amino acid substitution at residue 363 of the we sought to determine whether this protein, a known hSir2 protein, replacing the normally present histidine by deacetylase, could deacetylate human p53 in vitro. To tyrosine. We reasoned, by analogy with the Sir2 protein address this question we used bacterially expressed of yeast (Tanny et al., 1999) , that this substitution would murine Sir2, substituted for human Sir2 because of low result in alteration of the highly conserved catalytic site yields of the human protein. As substrate in these reacof the hSir2 protein, the loss of its deacetylase activity, tions, we used a 20 residue-long oligopeptide that conand the acquisition of a dominant-negative function.
tains the sequence corresponding to residues 368-These vector constructs were used to express hSir2 by 386ϩCys of the human p53 protein. The lysine residues transfection and by retroviral infection.
in this oligopeptide corresponding to residues 373 and We also developed a polyclonal rabbit antibody that 382 of the p53 protein were synthesized in an acetylated specifically recognizes the C-terminal portion of hSir2; form. These two residues of p53 are known to be acetits specificity was validated both by the results of immuylated in vivo by p300 (Gu and Roeder, 1997) following noprecipitation and Western blotting presented in Fig . After incubation with pressed hSir2 proteins detected in these assays mSir2␣, we detected alterations of this oligopeptide submigrated as a protein species of 120 kilodalton (kDa) strate by high-pressure liquid chromatography (HPLC). (Figure 1A ). Immunofluorescent staining of the hSir2 proAs mentioned, the deacetylase activity of Sir2 utilizes tein using our hSir2 antibody revealed nuclear localiza-NAD as a cofactor (Smith et al., 2000). In the absence tion ( Figure 1B) . of added NAD, incubation of mSir2␣ with the p53 oligoTo test for possible physical interactions between peptide gave rise to a single prominent peak (peak 1) hSir2 and p53, we cotransfected the pYESir2wt plasmid and a second, minor peak (peak 2) when the incubated and a vector expressing wt p53 under the control of material was analyzed by HPLC; these two peaks correthe cytomegalovirus promoter (pCMV-wtp53) transiently sponded to the monomeric and dimeric forms of the into H1299 human lung carcinoma cells. These cells acetylated peptide, respectively (Figure 2A ). In contrast, have a homozygous deletion of the p53 gene (Mitsudomi incubation of this oligopeptide and mSir2␣ in the preset al., 1992). Cell lysates were subsequently mixed with ence of 1 mM NAD produced a singly deacetylated spethe rabbit anti-hSir2 antibody and the resulting immune cies as the major product (peak 3, Figure 2B ). Edman complexes were collected and analyzed by immunoblotsequencing of this singly deacetylated species revealed ting with the Ab-6 anti-p53 antibody ( Figure 1D ). As that mSir2␣ preferentially deacetylated the residue corindicated in Figure 1D , immunoprecipitation of hSir2 responding to Lys382 of p53 ( Figures 2E-2H ) while havfrom lysates of these cotransfected cells resulted in ing relatively little effect on the acetylated Lys373 resicoprecipitation of p53. We also detected this interaction due. Furthermore, a catalytically inactive mutant form reciprocally by using the Ab-6 anti-p53 antibody for imof mSir2␣, termed H355A, was unable to deacetylate munoprecipitation and our anti-hSir2 antibody for probthe acetylated p53 peptide ( Figure 2D ). Like the H363Y ing of the blotted precipitate ( Figure 1C ). These observamutant version of hSir2, this H353A mutant carries a tions provided the first indications that hSir2 and p53 substitution in residue 353, in this case an alanine in can form physical complexes with one another in vivo.
We also determined whether hSir2 could form complace of the normally present histidine. These results provided evidence that the acetylated p53 peptide could We used this system to determine whether hSir2 could deacetylate the ectopically expressed p53 protein at its serve as a substrate for mSir2␣ and indicated that the de-acetylation of p53 at Lys382 by mammalian Sir2 is K382 residue in H1299 cells. To gauge the levels of acetylation of p53 at Lys382, we used a rabbit polyclonal specific and not the result of an indiscriminate deacetylase function.
antibody, termed Ab-1 which had been raised against the acetylated K382 of p53 protein. cluded further that this reduction of acetylated p53 levsubstrate specificity of hSir2 and not a nonspecific consequence of its overexpression. els was achieved by the direct action of the hSir2 enzyme on acetylated p53 substrate.
We also introduced into these H1299 cells the hSir2HY vector which expresses the mutant, catalytically inactive Effects of TSA on hSir2 Detection of endogenous acetylated p53 in most cell hSir2. In our assay, this mutant failed to deacetylate p53 efficiently, indicating that the catalytic activity of the types is a difficult task due to the metabolic instability of p53 protein and the resulting need to process and introduced wild-type hSIR2 gene product was required for specific deacetylation of p53 Lys382 (Figure 3A , lane analyze large amounts of extracted protein. It appears that the deacetylase inhibitor trichostatin A (TSA) can 7). However, we did observe a small amount of deacetylase activity at 2-fold higher hSir2HY plasmid concentraincrease the levels of acetylated p53 protein in cells (Sakaguchi et al., 1998) . This is likely due to inhibition tions (lane 8).
Finally, as a measure of the substrate specificity of by TSA of non-hSir2 deacetylases that target p53 protein. At the same time, in vitro studies have indicated hSir2, we gauged its effects on acetylated histone, specifically the acetylated lysine 9 residue of histone H3.
that Sir2 belongs to a class of deacetylases that are resistant to TSA inhibition (Imai et al., 2000). Together We monitored H3 Lys9 acetylation through use of the 9671S monoclonal antibody which specifically recogthese observations suggested the usefulness of including TSA in our in vivo assays. To confirm the resistance nizes histone H3 that is acetylated at this position (Experimental Procedures). hSir2 overexpression did not of hSir2 to this drug and examine the utility of using TSA, we subjected MCF-7L (Experimental Procedures) alter the acetylation of histone H3Lys9 ( Figure 3B ). Taken together, these results provide evidence that the cells and their derivatives infected with either control vector, hSir2wt or hSir2HY retroviral vectors to 6 Gy deacetylation of p53 Lys382 in vivo reflects a defined pression of the telomerase enzyme. We note that our As indicated in Figure 3C , wild-type hSir2 was able previous studies indicated that expression of teloto efficiently deacetylate p53 either in the presence or merase in these cells, undertaken to extend their life absence of TSA. In contrast, the mutant hSir2HY was span, had no effect on either the activation of p53 protein unable to deacetylate p53. Effects of hSir2 on the Transcriptional Activity of p53 Protein hSir2. We also wished to measure the levels of wildtype and mutant hSir2 that were required to alter the We also investigated the possible effects of hSir2 on the activity of p53 as a transcription factor. To do so, acetylated state of p53 in the BJT cells ectopically expressing one or the other of these hSir2 proteins.
we cotransfected H1299 cells transiently with a p53 expression plasmid and a reporter construct in which the To address these issues, we exposed the BJT cells and their derivatives to 6 Gy of ionizing radiation in the promoter of the p21 WAF1 gene (el-Deiry et al., 1993), a known target of transcriptional activation by p53, drives presence of 0.1 M TSA. We subsequently collected cells before irradiation and at five time points post-irradiexpression of a luciferase reporter gene (Vaziri et al., 1997). As indicated in Figure 4A , luciferase activity ination. Cells were lysed and equal amounts of protein were resolved by gel electrophoresis and then transcreased in response to increasing amounts of cotransfected wild-type p53 expression vector. Conversely, the ferred to immunoblots. As in earlier experiments, we used as a probe in these immunoblots the polyclonal activity of the p21 promoter was suppressed in a dosedependent fashion by coexpression of wild-type hSir2. rabbit antiserum (Ab-1) which specifically recognizes the acetylated K382 form of p53. These blots were seWe note that there remains a possibility that hSir2 can also suppress the p21 promoter in a p53-independent quentially reprobed with a polyclonal p53 antibody, with a ␤ actin antibody as a loading control, and with the fashion, since luciferase activity was also reduced below that of the control (lane 1) cells in which no ectopic anti-hSir2 antibody.
As anticipated, following 6 Gy of ionizing radiation p53 was expressed. The catalytically inactive hSir2HY mutant had no effect on the activity of this promoter we observed a 1.5-to 2-fold increase in the level of acetylated p53 protein, indicated by the level of p53 ( Figure 4A ). To gauge the specificity of hSir2 in affecting promoter activity, we used as control a constitutively protein recognized by the Ab-1 antiserum ( Figure 3E) . A 4-fold increase in hSir2 level, achieved through ectopic active SV40 promoter linked to the luciferase gene. Expression of this control construct was not affected by expression of hSir2, sufficed to block the radiationinduced increase in acetylated K382 p53 protein (Figure increasing amounts of the hSir2 vector expressed at any level ( Figure 4B ). 3E). In contrast, we observed that the ectopic expression at comparable levels of the catalytically inactive
The above experiments relied on ectopic gene expression and may not necessarily reflect how p21 WAF1 expreshSir2HY increased the radiation-induced levels of p53 acetylated at residue K382 ( Figure 3B ). This observation sion is affected by hSir2 under more physiologic conditions including exposure to ionizing radiation. To provided support for the notion that the hSir2HY mutant protein was able to act in a dominant-negative fashion address this issue, we used MCF-7L cells cultured in the absence of TSA. Like the parental MCF-7 cells, those in BJT cells.
We considered it possible that the observed inhibition from the MCF-7L subline can induce p53 protein normally in response to radiation. These cells were infected of acetylated p53 described above might be attributable to a reduction in the levels of total p53 in these cells. stably with the retroviral vectors expressing wild-type hSir2 and dominant-negative hSir2HY. We then exposed However, a reprobing of this immunoblot with a polyclonal anti-p53 antibody showed normal stabilization of these cells to 6 Gy of ionizing radiation and subsequently measured total p53 and p21 WAF1 protein levels ( Figure  p53 in control cells in response to DNA damage and at most very slightly reduced steady-state levels of p53 in 4C). p53 protein levels increased normally in these polyclonal cell populations in response to irradiation. A the presence of ectopically expressed wild-type hSir2 ( Figure 3E ). This lower level of p53 could not account 4-fold overexpression of wild-type hSir2 resulted in a slight but clearly detectable decrease of p21 WAF1 protein for the much larger decrease in acetylated p53 observed in the presence of wild-type hSir2. Moreover, the mutant in these cells ( Figure 4C ). This decrease was not sufficient to abrogate the p53-dependent G1 checkpoint as hSir2HY also reduced the stability of p53 protein slightly despite its ability to cause increased acetylation of this measured by analysis of DNA content (data not shown). In contrast, the levels of p21 WAF1 protein in irradiated protein ( Figure 3E ). Hence, while hSir2 was able to reverse the radiation-induced acetylation of p53 in these MCF-7L cells expressing the hSir2HY protein were significantly (‫-3ف‬fold) higher when compared with parental cells, it had only minimal effects on the steady state level of p53 induced by exposure to radiation.
MCF-7LP cells infected with an empty control vector. Consistent with this effect on p21 protein levels, we We also made several observations regarding the kinetics of p53 acetylation ( Figure 3E ). Ectopic expression found that measurements of the K382-acetylated fraction of p53 in lysates of irradiated hSir2HY-expressing of hSir2 was able to efficiently block p53 acetylation. In contrast, expression of the mutant hSir2HY in BJT cells MCF-7LP cells showed a large increase when compared with the irradiated controls that did not express hSir2HY had the opposite effect: it caused premature induction Gy of ionizing radiation and its effect on p53 acetylation at K382. 1 mg of total protein lysates was subjected to immunoprecipitation with Ab-1 (top panel), and the blot was probed for p53 with Ab-6. The remaining lysates were immunoprecipitated with SC6423 polyclonal rabbit antibody for total p53 protein, and the resulting p53 in the precipitate was detected by Ab-6 (second panel). Equal amounts of protein from the aforementioned experiment were also quantified to ensure equal total protein was loaded and that total p53 levels were comparable to each other using Ab-6 and ␤ actin antibodies.
( Figure 4D, upper panel) . Furthermore, immunoprecipiwt p53-expressing vector, induces apoptosis as gauged tation with a polyclonal anti-p53 rabbit antibody of these by the display of the cell surface annexin V antigen lysates, following depletion by incubation with the Ab-1 ( Figure 5A ). The apoptotic response in H1299 cells transantibody indicated that the majority of p53 in the irradifected with p53 was potentiated in a dose-dependent ated MCF-7LhSir2HY cells was in an acetylated state manner in cells cotransfected the dominant-negative ( Figure 4D ). Taken together, these experiments conhSir2HY expression plasmid. Expression of hSir2 on its verged on the conclusion that the hSir2HY mutant funcown did not significantly change the level of apoptosis. tions as a dominant-negative protein by quantitatively Although this assay is accepted widely for measuring inhibiting the p53 deacetylation at K382. p53-dependent apoptosis, it relies on ectopic expression of p53 under nonphysiologic conditions. In order to address this problem, we made use of BJT cells which Potentiation of p53-Dependent Apoptosis contain a functional endogenous p53 protein. These by hSir2HY cells undergo p53-dependent apoptosis upon exposure Given that dominant-negative inhibition of hSir2 can poto high concentration of the chemotherapeutic drug VPtentiate the ability of p53 to induce p21 which an incipient cancer cell can rid itself of p53 func- 
